Fibrinogen concentrate in cardiovascular surgery: A meta-analysis of randomized controlled trials

Anesthesia and Analgesia

Volumn 127, Issue 3, 2018, Pages 612-621

  Li, Jing Yi ^a,b   Gong, Junsong ^b,c   Zhu, Fang ^b   Moodie, Jessica ^b   Newitt, Amy ^b   Uruthiramoorthy, Lavanya ^b   Cheng, Davy ^b,d   Martin, Janet ^b,d  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c FUWAI HOSPITAL   (China)

^d WESTERN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN CONCENTRATE; PLACEBO; FIBRINOGEN; HEMOSTATIC AGENT;

ALL CAUSE MORTALITY; AORTIC SURGERY; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR RISK; CARDIOVASCULAR SURGERY; CEREBROVASCULAR ACCIDENT; CLINICAL OUTCOME; COCHRANE LIBRARY; EMBASE; ERYTHROCYTE TRANSFUSION; FIBRINOGEN BLOOD LEVEL; HEALTH CARE QUALITY; HEART INFARCTION; HEART SURGERY; HUMAN; MEDLINE; META ANALYSIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; WEB OF SCIENCE; BLOOD TRANSFUSION; INTRAVENOUS DRUG ADMINISTRATION; PROCEDURES; TRENDS;

BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; ERYTHROCYTE TRANSFUSION; FIBRINOGEN; HEMOSTATICS; HUMANS; INFUSIONS, INTRAVENOUS; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85053513549     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000003508     Document Type: Article

References (41)

1. Nuttall GA, Oliver WC, Santrach PJ, et al. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology. 2001; 94:773-781.
2. Levi M, Cromheecke ME, de Jonge E, et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet. 1999; 354:1940-1947.
3. Achneck HE, Sileshi B, Parikh A, Milano CA, Welsby IJ, Lawson JH. Pathophysiology of bleeding and clotting in the cardiac surgery patient: from vascular endothelium to circulatory assist device surface. Circulation. 2010; 122:2068-2077.
4. Sniecinski RM, Levy JH. Bleeding and management of coagulopathy. J Thorac Cardiovasc Surg. 2011; 142:662-667.
5. Görlinger K, Shore-Lesserson L, Dirkmann D, Hanke AA, Rahe-Meyer N, Tanaka KA. Management of hemorrhage in cardiothoracic surgery. J Cardiothorac Vasc Anesth. 2013; 27:S20-S34.
6. Menkis AH, Martin J, Cheng DC, et al. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. Innovations (Phila). 2012; 7:229-241.
7. Blome M, Isgro F, Kiessling AH, et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost. 2005; 93:1101-1107.
8. Gielen C, Dekkers O, Stijnen T, et al. The effects of pre- and postoperative fibrinogen levels on blood loss after cardiac surgery: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. 2014; 18:292-298.
9. Waldén K, Jeppsson A, Nasic S, Backlund E, Karlsson M. Low preoperative fibrinogen plasma concentration is associated with excessive bleeding after cardiac operations. Ann Thorac Surg. 2014; 97:1199-1206.
10. Pillai RC, Fraser JF, Ziegenfuss M, Bhaskar B. Influence of circulating levels of fibrinogen and perioperative coagulation parameters on predicting postoperative blood loss in cardiac surgery: a prospective observational study. J Card Surg. 2014; 29:189-195.
11. Karlsson M, Ternström L, Hyllner M, Baghaei F, Nilsson S, Jeppsson A. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion. 2008; 48:2152-2158.
12. Kindo M, Hoang Minh T, Gerelli S, et al. Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass. Thromb Res. 2014; 134:360-368.
13. Ternström L, Radulovic V, Karlsson M, et al. Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: a prospective observational study. Thromb Res. 2010; 126:e128-e133.
14. Reinhöfer M, Brauer M, Franke U, Barz D, Marx G, Lösche W. The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis. 2008; 19:212-219.
15. Görlinger K, Dirkmann D, Hanke AA, et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology. 2011; 115:1179-1191.
16. Hanke AA, Herold U, Dirkmann D, Tsagakis K, Jakob H, Görlinger K. Thromboelastometry based early goal-directed coagulation management reduces blood transfusion requirements, adverse events, and costs in acute type a aortic dissection: a pilot study. Transfus Med Hemother. 2012; 39:121-128.
17. Weber CF, Görlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology. 2012; 117:531-547.
18. Rahe-Meyer N, Pichlmaier M, Haverich A, et al. Bleeding management with fibrinogen concentrate targeting a highnormal plasma fibrinogen level: a pilot study. Br J Anaesth. 2009; 102:785-792.
19. Rahe-Meyer N, Solomon C, Winterhalter M, et al. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg. 2009; 138:694-702.
20. Rahe-Meyer N. Fibrinogen concentrate in the treatment of severe bleeding after aortic aneurysm graft surgery. Thromb Res. 2011; 128(suppl 1):S17-S19.
21. Rahe-Meyer N, Solomon C, Hanke A, et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology. 2013; 118:40-50.
22. Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group. Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. J Am Heart Assoc. 2015; 4:e002066.
23. Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016. Eur J Anaesthesiol. 2017; 34:332-395.
24. Wikkelso A, Lunde J, Johansen M, et al. Fibrinogen concentrate in bleeding patients. Cochrane Database Syst Rev. 2013; 8:CD008864.
25. Azevedo Maranhão Cardoso TA, Nigro Neto C, Santos Silva CG, Lobo da Rocha P, Iosto HH. Use of lyophilized fibrinogen concentrate in cardiac surgery: a systematic review. Heart Lung Vessel. 2015; 7:47-53.
26. Lin DM, Murphy LS, Tran MH. Use of prothrombin complex concentrates and fibrinogen concentrates in the perioperative setting: a systematic review. Transfus Med Rev. 2013; 27: 91-104.
27. Fominskiy E, Nepomniashchikh VA, Lomivorotov VV, et al. Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2016; 30:1196-1204.
28. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. Updated March 2011. London, UK: The Cochrane Collaboration; 2011. Available at: http://handbook.cochrane.org. Accessed July 2016.
29. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. BM J. 2009; 339:b2535.
30. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BM J. 2003; 327:557-560.
31. Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014.
32. Jeppsson A, Waldén K, Roman-Emanuel C, Thimour-Bergström L, Karlsson M. Preoperative supplementation with fibrinogen concentrate in cardiac surgery: a randomized controlled study. Br J Anaesth. 2016; 116:208-214.
33. Karlsson M, Ternström L, Hyllner M, et al. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost. 2009; 102:137-144.
34. Rahe-Meyer N, Levy JH, Mazer CD, et al. Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy. Br J Anaesth. 2016; 117:41-51.
35. Sadeghi M, Atefyekta R, Azimaraghi O, et al. A randomized, double blind trial of prophylactic fibrinogen to reduce bleeding in cardiac surgery. Braz J Anesthesiol. 2014; 64:253-257.
36. Tanaka KA, Egan K, Szlam F, et al. Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion. Transfusion. 2014; 54:109-118.
37. Bilecen S, de Groot JA, Kalkman CJ, et al. Effect of fibrinogen concentrate on intraoperative blood loss among patients with intraoperative bleeding during high-risk cardiac surgery: a randomized clinical trial. JAMA. 2017; 317:738-747.
38. Nova Scotia Health Authority. Prospective double blinded randomized control study of the use of fibrinogen in high-risk cardiac surgery. In: ClinicalTrials.gov. Bethesda, MD: National Library of Medicine (US); 2000. Available at: https://clinicaltrials.gov/show/NCT01623531NLMIdentifier:NCT01623531. Accessed July 27, 2016.
39. Mashhad University of Medical Sciences. Effect of fibrinogen on bleeding after cardiac surgery. In: Irct.ir. Mashhad, Iran: Central Library Building, Iran University. Available at: http://www.irct.ir/searchresult.php?id=14489&number=1IRCT2013082714489N1. Accessed May 2017.
40. American Society of Anesthesia Perioperative Blood Management. Practice guidelines for perioperative blood management. An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology. 2015; 122:241-275.
41. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013; 30:270-382.